IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q4 2021 Holdings

Filed 2022-02-16 | 20 holdings | $412.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte(PCVX)Common92243G108$99.2K4,168,71824.0%
Vera(VERA)Common92337R101$78.5K2,960,23119.0%
JasperCommon471871103$44.1K5,628,55810.7%
eFFECTORCommon28202V108$39.9K4,822,1149.7%
Adicet(TORCEUR)Common007002108$36.9K2,115,3858.9%
Phathom(PHAT)Common71722W107$23.6K1,203,1355.7%
Sierra OncologyCommon82640U107$19.1K876,6564.6%
Reneo(RPHM)Common75974E103$17.7K2,073,9574.3%
Verona(VRNA)SPONDS ADR925050106$16.3K2,457,4994.0%
SientraCommon82621J105$8.6K2,349,8272.1%
Spruce BioCommonE5209E109$8.0K1,792,5181.9%
NucanaADR67022C106$7.9K3,333,3331.9%
ParatekCommon699374302$4.7K1,041,1311.1%
SolenoCommon834203200$4.2K10,302,6021.0%
Exicure(XCUR)Common30205M101$1.4K6,977,0000.3%
Aeglea(AGLEUSD)Common00773J103$1.1K240,5000.3%
Molecular TemplatesCommon608550109$780200,0000.2%
Cymabay(CBAYUSD)Common23257D103$442131,0360.1%
ObsevaCommonH5861P103$17487,9990.0%
OcugenCommon43358V109$327,1110.0%